MARK GOLDSTEIN MD NPI 1679568885

NPI Details

Mark Goldstein, MD is a rheumatology internal medicine in Staten Island, NY with 47 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Mark Goldstein, MD NPI is 1679568885. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: NEW YORK MEDICAL COLLEGE
Graduation Year:1979

The provider's business location address is:

1478 VICTORY BLVD
STATEN ISLAND, NY
ZIP 10301-915
Phone: (718) 447-0055

The NPI 1679568885 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg (HCPCS:J7322)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, methylprednisolone acetate, 20 mg (HCPCS:J1020)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Aspiration and/or injection of fluid from small joint (HCPCS:20600)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)

The enumeration date for this NPI number is 9/14/2005 and was last updated on 2/28/2012.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.